Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey-Reference-Cited by-同舟云学术

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey

Published:2020-06-18 Issue:8 Volume:34 Page:2260-2261
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Breccia Massimo,Abruzzese Elisabetta^ORCID,Bocchia Monica,Bonifacio Massimiliano^ORCID,Castagnetti Fausto,Fava Carmen^ORCID,Galimberti Sara^ORCID,Gozzini Antonella,Gugliotta Gabriele,Iurlo Alessandra,Latagliata Roberto,Luciano Luigiana,Pregno Patrizia,Rege-Cambrin Giovanna,Rosti Gianantonio,Stagno Fabio^ORCID,Tiribelli Mario^ORCID,Foà Robin^ORCID,Saglio Giuseppe,Maria Cristina Miggiano Maria,Isabella Capodanno,Vincenzo Accurso,Federica Sorà,Debora Luzi,Mario Annunziata,Immacolata Attolico,Alessandra Malato,Rosaria Sancetta,Chiara Elena,Sara Barulli,Rita Scortechini Anna,Sabrina Leonetti-Crescenzi,Agostino Tafuri,Francesco Cavazzini,Giovanni Caocci,Alessandro Lucchesi,Davide Rapezzi,Michele Pizzuti,Gianni Binotto,Tamara Intermesoli,Alessandro Maggi,Elena Crisa’,Monica Crugnola,Mariella D’ Adda,Germana Beltrami,Francesca Lunghi,Iolanda –Donatella Vincelli,Grazia Sanpaolo,Luca Franceschini,Sabina Russo,Gaetano La Barba,Luciano Levato,

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0904-z.pdf

Reference4 articles.

1. Coleman CM, Sisk JM, Mingo RM, Nelson EA, White JM, Frieman MB. Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and middle east respiratory syndrome coronavirus fusion. J Virol. 2016;90:8924–8933.

2. Sisk JM, Frieman MB, Machamer CE. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. J Gen Virol. 2018;99:619–630.

3. Li W, Wang D, Guo J, Yuan G, Yang Z, Gale RP, et al. COVID-19 in persons with chronic myeloid leukemia. Leukemia. 2020:1–6. https://doi.org/10.1038/s41375-020-0853-6.